Abstract
Study design:
Clinical case report with comments by colleagues from Sweden, Poland, Spain, Brazil, Japan, Belgium and Switzerland.
Objectives:
To discuss the role of disodium etidronate therapy for prevention of calcium phosphate vesical calculi in persons with spinal cord injury, who have hypercalciuria and biochemical evidence of increased bone resorption.
Setting:
Regional Spinal Injuries Centre, Southport, UK.
Methods:
A 21-year-old male sustained paraplegia (T-10; ASIA scale: A) in a road traffic accident in June 2001. He had an indwelling urethral catheter until the end of August 2001, when he started self-catheterisation. He developed bladder stones and electrohydraulic lithotripsy (EHL) was performed in May 2002. All stone fragments were removed. Recurrence of vesical calculi was noted in October 2002. These stones were fragmented by lithoclast lithotripsy in two sessions, in December 2002 and February 2003; all stone fragments were removed at the end of the second session. This patient reverted to indwelling catheter drainage when vesical calculi recurred. In September 2003, X-ray of the abdomen showed recurrence of vesical calculi. By February 2004, the stones had increased in size and number. EHL of vesical calculi was again performed in April 2004. Complete clearance was achieved.
Results:
A 24-h urinalysis detected hypercalciuria – 18.7 mmol/day (reference range: 2.5–7.5). Biochemical analysis of vesical calculus revealed calcium phosphate (85%) and magnesium ammonium phosphate (15%). Plasma C-terminal telopeptide (CTX) was increased – 1.06 ng/ml (reference range: 0.1–0.5 ng/ml). Free deoxypyridinoline/creatinine ratio (fDPD/Cr) in urine was also increased – 20.2 (reference range: 2.3–5.4). In April 2004, this patient was prescribed disodium etidronate 400 mg day. Nearly 3 months after commencing therapy with etidronate, plasma CTX decreased to 0.87 ng/ml. fDPD/Cr in urine also decreased to 12.4. After 4 months of etidronate therapy, 24-h urinary calcium excretion had decreased to 6.1 mmol/day.
Conclusion:
Etidronate (400 mg daily) is a very effective inhibitor of calcium phosphate crystallisation. Etidronate decreased urinary excretion of calcium, an important factor in prevention of calcium phosphate bladder stones. Etidronate therapy is not a substitute for other well-established methods for prevention of vesical calculi in spinal cord injury patients, for example, large fluid intake, avoiding long-term catheter drainage. Intermittent therapy with etidronate may be considered in selected patients, in whom hypercalciuria persists after instituting nonpharmacological therapy for an adequate period, for example, early mobilisation, weight-bearing exercises and functional electrical stimulation. However, possible side effects of etidronate and the fact that etidronate is not licensed in United Kingdom for prevention of urolithiasis, should be borne in mind.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Ord J, Lunn D, Reynard J . Bladder management and risk of bladder stone formation in spinal cord injured patients. J Urol 2003; 170: 1734–1737.
Lamid S, El Ghatit AZ, Melvin JL . Relationship of hypercalciuria to diet and bladder stone formation in spinal cord injury patients. Am J Phys Med 1984; 63: 182–187.
Singh PP, Pendse AK, Rathore V, Kiran R, Dashora PK . Interdependence of urinary factors in calcareous bladder stone patients. Int Urol Nephrol 1989; 21: 145–151.
Gupta M, Tuncay OL, Valderrama E, Smith AD . Inhibition of calcium oxalate urolithiasis in a rat model of lithogenesis using bisphosphonates. J Endourol 1997; 11: l–4.
Bone III HG, Zerwekh JE, Britton F, Pak CY . Treatment of calcium urolithiasis with diphosphonate: efficacy and hazards. J Urol 1979; 121: 568–571.
Heilberg IP et al. Effect of etidronate treatment on bone mass of male nephrolithiasis patients with idiopathic hypercalciuria and osteopenia. Nephron 1998; 79: 430–437.
Lamm DL, Johnson SA, Friedlander AM, Gittes RF . Medical therapy of experimental infection stones. Urology 1977; 10: 418–421.
Ebisuno S et al. Effects of etidronate disodium on crystallizations in synthetic urine and calcium oxalate crystal adhesion to Madin-Darby canine kidney (MDCK) cells. Int J Urol 1998; 5: 582–587.
Ott SM . Osteoporosis in women with spinal cord injuries. Phys Med Rehabil Clin N Am 2001; 12: 111–131.
Sato Y, Asoh T, Kaji M, Oizumi K . Beneficial effect of intermittent cyclical etidronate therapy in hemiplegic patients following an acute stroke. J Bone Miner Res 2000; 15: 2487–2494.
Adami S, Zamberlan N . Adverse effects of bisphosphonates. A comparative review. Drug Saf 1996; 14: 158–170.
Wolffenbuttel BH, van der Klauw MM . Psychiatric side effects associated with diphosphonate treatment. Ned Tijdschr Geneeskd 2003; 147: 35–37.
Pak CY, Ohata M, Holt K . Effect of diphosphonate on crystallization of calcium oxalate in vitro. Kidney Int 1975; 7: 154–160.
Ruml LA, Dubois SK, Roberts ML, Pak CY . Prevention of hypercalciuria and stone-forming propensity during prolonged bed rest by alendronate. J Bone Miner Res 1995; 10: 655–662.
Gardner BP, Parsons KF . Upper tract dilatation and stones. In: KF Parsons, JM Fitspatrick (eds). Practical Urology in Spinal Cord Injury. Springer Verlag: London 1991, pp 43–56, Chapter 5.
Wyndaele JJ, De Sy W, Claessens H . Evaluation of different methods of bladder drainage used in the early care of spinal cord injury patients. Paraplegia 1985; 23: 18–26.
Conley SB, Shackelford GD, Robson AM . Severe immobilization hypercalcemia, renal insufficiency and calcification. Pediatrics 1979; 63: 142–145.
Issekutz Jr B, Blizzard JJ, Birkhead NC, Rodahl K . Effect of prolonged bed rest on urinary calcium output. J Appl Physiol 1966; 21: 1013–1020.
Burr RG, Nuseibeh I . Diuresis and urinary saturation in patients with neurogenic bladder. Invest Urol 1981; 18: 331–333.
Acknowledgements
This work is dedicated to the memory of Mr KR Krishnan, who was Consultant in Spinal Injuries, Southport from 1971 to 1996 and a member of International Medical Society of Paraplegia (presently, International Spinal Cord Society).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vaidyanathan, S., Watson, I., Jonsson, O. et al. Recurrent vesical calculi, hypercalciuria and biochemical evidence of increased bone resorption in an adult male with paraplegia due to spinal cord injury: is there a role for intermittent oral disodium etidronate therapy for prevention of calcium phosphate bladder stones?. Spinal Cord 43, 269–277 (2005). https://doi.org/10.1038/sj.sc.3101713
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.sc.3101713
Keywords
This article is cited by
-
Treatment of immobilization hypercalciuria using weekly alendronate in two quadriplegic patients
International Urology and Nephrology (2008)
